Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice
Sumita Mishra(Virginia Cooperative Extension), David A. Kass(Johns Hopkins University)
Cited by 41
Related Papers
Oxidant stress from nitric oxide synthase–3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load
|Journal of Clinical Investigation|2005|445
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
|Nature|2015|346
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
|Journal of Clinical Investigation|2011|328
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
|Journal of Clinical Investigation|1999|259
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
|Journal of Clinical Investigation|2002|251